Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer
- DOI
- 10.1200/cci.24.00133
- Published
- 2024-12
- Container
- JCO Clinical Cancer Informatics
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/cci.24.00133,
title = {Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer},
author = {Chiharu Sako and Chong Duan and Kevin Maresca and Sean Kent and Taly Gilat Schmidt and Hugo J.W.L. Aerts and Ravi B. Parikh and George R. Simon and Petr Jordan},
year = {2024},
journal = {JCO Clinical Cancer Informatics},
doi = {10.1200/cci.24.00133},
url = {https://doi.org/10.1200/cci.24.00133}
}RIS
TY - JOUR TI - Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer AU - Chiharu Sako AU - Chong Duan AU - Kevin Maresca AU - Sean Kent AU - Taly Gilat Schmidt AU - Hugo J.W.L. Aerts AU - Ravi B. Parikh AU - George R. Simon AU - Petr Jordan PY - 2024 JO - JCO Clinical Cancer Informatics DO - 10.1200/cci.24.00133 UR - https://doi.org/10.1200/cci.24.00133 ER -
APA
Sako, C., Duan, C., Maresca, K., Kent, S., Schmidt, T. G., Aerts, H. J., Parikh, R. B., Simon, G. R., & Jordan, P. (2024). Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.24.00133
Source records
- crossref · retrieved 2026-09-27T10:24:35.169Z